article thumbnail

CDSCO releases regulatory guidelines for sampling of drugs, cosmetics and medical devices

AuroBlog - Aurous Healthcare Clinical Trials blog

In its efforts to streamline and rationalise the sampling procedure and maintain a centralised monthly database the Central Drugs Standard Control Organisation (CDSCO) has released the final version of the regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of the Central and State drug authorities.

Cosmetics 198
article thumbnail

Jan Vishwas Act amendment on Drugs & Cosmetics Act to be in force from December

AuroBlog - Aurous Healthcare Clinical Trials blog

The amended provisions under the Jan Vishwas (Amendment of Provisions) Act, 2023 notified by the Central government last year for removal of stringent punishments such as imprisonment from some of the Sections of the Drugs and Cosmetics Act, 1940, will be in force from December 31, 2024.

Cosmetics 158
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With trial win, AbbVie cues up Botox for another cosmetic indication

Fierce Pharma

. | Already approved as an injection to reduce wrinkles in the forehead and around the eyes, AbbVie's Botox is in position to expand its cosmetic uses to the moderate to severe form of platysma prominence, a condition which causes muscle bands to protrude from the neck.

Botox 110
article thumbnail

Industry concerned over lack of discussion on proposed New Drugs, Medical Devices & Cosmetics Bill

AuroBlog - Aurous Healthcare Clinical Trials blog

Even as the Centre has listed the New Drugs, Medical Devices and Cosmetics Bill, 2023 to be tabled in Parliament during the current session, industry members are apprehensive that the new bill may mean centralisation of licensing and other powers to the Central drug regulatory authority and it may also have provisions which may harm […]

Cosmetics 167
article thumbnail

Ten organisations including medical devices industry demand recall of New Drugs, Medical Devices & Cosmetics Bill

AuroBlog - Aurous Healthcare Clinical Trials blog

Ten collective stakeholders of Indian healthcare industry, including the industry associations of medical devices manufacturers, patient interest group, and healthcare providers, have jointly demanded to the Union health minister Dr Mansukh Mandaviya to recall the New Drugs, Medical Devices & Cosmetics Bill, 2023 that is listed to be tabled in (..)

Cosmetics 153
article thumbnail

January 31, 2024: Improving the Public’s Understanding of the FDA, in This Week’s PCT Grand Rounds

Rethinking Clinical Trials

Winckler is the chief executive officer of the Reagan-Udall Foundation for the FDA, a nonprofit organization created by Congress “to advance the mission of the FDA to modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety.” Join the online meeting.

Cosmetics 152
article thumbnail

Ayush Ministry to amend D&C Rules mandating cGMP for homoeopathic drug manufacturing license

AuroBlog - Aurous Healthcare Clinical Trials blog

The Union Ministry of Ayush will soon amend the Drugs and Cosmetic Rules, 1945 to mandate good manufacturing practices for Homoeopathy drug manufacturing, stipulating procedures for loan licensing in the system of Homoeopathy and specifying timelines for issuance of license, among others.

Licensing 157